Key metrics and charts across all fundamental categories.
Stock price and market valuation
GEN trades at $23.56, a 13.9% decrease year-over-year. Market capitalization stands at $14.23B, down 15.4% from the prior year. Track GEN price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$5.00B in TTM revenue grew 27.1% YoY, reaching $1.28B last quarter. TTM EBITDA of $2.61B on operating income of $803.00M shows growth is flowing through. Net income of $973.00M TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $15.59B in assets and $8.02B in long-term debt, the D/E of 3.1 indicates elevated leverage — the company has significant financial risk and may struggle in a downturn.
Price multiples and return ratios
At 14.6x P/E, the stock trades below market averages — potentially undervalued. P/S of 2.8x and P/B of 5.5x provide additional context. Below-market P/E with growing revenue suggests a potential buying opportunity — the stock may be undervalued relative to its fundamentals.
Operating efficiency and return metrics
Op. margin of 62.6% is up 21.3% YoY — cost efficiency is improving. Net margin at 39.9% and gross margin of 78.5%. ROE of 37.3% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $476.00M on $479.00M in operating cash flow. The FCF / Net Income ratio of 0.5x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $411.00M provide financial flexibility.
